OBI Pharma (ROCO:4174) Cyclically Adjusted FCF per Share: NT$-17.22 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4174 OBI Pharma Inc ROCO:4174
28 GF Score
Price NT$25.55
! 8 Warning Signs
View Full Analysis

What is OBI Pharma Cyclically Adjusted FCF per Share?

OBI Pharma ROCO:4174 -2.85% 28 Cyclically Adjusted FCF per Share is NT$-17.22 as of Mar. 2026. GuruFocus rates ROCO:4174 with a GF Score™ of 28/100. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

OBI Pharma's adjusted free cash flow per share for the three months ended in Mar. 2026 was NT$-2.727. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-17.22 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of OBI Pharma was -7.00% per year. The lowest was -7.00% per year. And the median was -7.00% per year.

As of today (2026-07-30), OBI Pharma's current stock price is NT$25.55. OBI Pharma's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was NT$-17.22. OBI Pharma's Cyclically Adjusted Price-to-FCF of today is .


OBI Pharma  (ROCO:4174) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


OBI Pharma Cyclically Adjusted FCF per Share Related Terms


OBI Pharma Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for OBI Pharma's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OBI Pharma Cyclically Adjusted FCF per Share Chart

OBI Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -13.91 -14.48 -15.72 -17.04

OBI Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.24 -16.51 -16.88 -17.04 -17.22

ROCO:4174 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, OBI Pharma's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OBI Pharma Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where OBI Pharma's Cyclically Adjusted Price-to-FCF falls into.


ROCO:4174
28GF Score
OBI Pharma Inc ROCO:4174
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OBI Pharma Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OBI Pharma's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-2.727/330.2130*330.2130
=-2.727

Current CPI (Mar. 2026) = 330.2130.

OBI Pharma Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -1.869 241.018 -2.561
201609 -4.053 241.428 -5.543
201612 -2.776 241.432 -3.797
201703 -4.834 243.801 -6.547
201706 -2.188 244.955 -2.950
201709 -4.431 246.819 -5.928
201712 -2.919 246.524 -3.910
201803 -2.540 249.554 -3.361
201806 -0.278 251.989 -0.364
201809 -4.154 252.439 -5.434
201812 -3.438 251.233 -4.519
201903 -2.393 254.202 -3.109
201906 -3.006 256.143 -3.875
201909 -3.314 256.759 -4.262
201912 -3.406 256.974 -4.377
202003 -4.288 258.115 -5.486
202006 -7.335 257.797 -9.395
202009 -3.968 260.280 -5.034
202012 -2.830 260.474 -3.588
202103 -1.846 264.877 -2.301
202106 -2.539 271.696 -3.086
202109 -3.877 274.310 -4.667
202112 -4.975 278.802 -5.892
202203 -4.904 287.504 -5.632
202206 -4.102 296.311 -4.571
202209 -3.499 296.808 -3.893
202212 -4.782 296.797 -5.320
202303 -3.420 301.836 -3.742
202306 -3.844 305.109 -4.160
202309 -4.075 307.789 -4.372
202312 -3.956 306.746 -4.259
202403 -4.949 312.332 -5.232
202406 -4.467 314.175 -4.695
202409 -4.025 315.301 -4.215
202412 -3.148 315.605 -3.294
202503 -5.204 319.799 -5.373
202506 -3.685 322.561 -3.772
202509 -3.132 324.800 -3.184
202512 -3.712 324.054 -3.783
202603 -2.727 330.213 -2.727

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$-17.22 mean?
OBI Pharma (ROCO:4174) has a Cyclically Adjusted FCF per Share of NT$-17.22 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on OBI Pharma and its competitors.
Is OBI Pharma's Cyclically Adjusted FCF per Share too high?
OBI Pharma's current Cyclically Adjusted FCF per Share is NT$-17.22. Overall, OBI Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does OBI Pharma's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
OBI Pharma's Cyclically Adjusted FCF per Share of NT$-17.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on OBI Pharma and its competitors. OBI Pharma's current Cyclically Adjusted FCF per Share is NT$-17.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OBI Pharma stock overvalued right now?
OBI Pharma (ROCO:4174) has a current Cyclically Adjusted FCF per Share of NT$-17.22. The current Cyclically Adjusted FCF per Share is NT$-17.22. OBI Pharma's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For OBI Pharma (ROCO:4174), the current Cyclically Adjusted FCF per Share is NT$-17.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OBI Pharma Business Description

Address Zhongxiao East Road, 6th Floor, No. 508, Section 7, Nangang District, Taipei, TWN, 115
OBI Pharma Inc is engaged in the research and development of novel therapeutic agents and biologics for patients with unmet medical needs. The company has three reportable segments: the anti-cancer new drug segment, the botulinum toxin new drug segment, and the CDMO segment. Geographically, it generates the majority of its revenue from Taiwan.
28GF Score

Get the complete analysis for ROCO:4174

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.55
Price